SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

MLA

Morishita, Hiroki, et al. “SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.” Oncology, vol. 102, no. 11, 2024, pp. 960–68. EBSCOhost, https://doi.org/10.1159/000540247.

APA

Morishita, H., Otsuka, R., Murakami, K., Endo, S., Toyozumi, T., Matsumoto, Y., Shiraishi, T., Iida, S., Makiyama, T., Nishioka, Y., Hu, J., Maiyulan, A., & Matsubara, H. (2024). SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma. Oncology, 102(11), 960–968. https://doi.org/10.1159/000540247

Chicago

Morishita, Hiroki, Ryota Otsuka, Kentaro Murakami, Satoshi Endo, Takeshi Toyozumi, Yasunori Matsumoto, Tadashi Shiraishi, et al. 2024. “SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.” Oncology 102 (11): 960–68. doi:10.1159/000540247.